An Advanced Protocol-Driven Transition from Parenteral Prostanoids to Inhaled Trepostinil in Pulmonary Arterial Hypertension
Patients with pulmonary arterial hypertension (PAH) often require parenteral prostanoids to improve symptoms and signs of PAH. Complications of parenteral prostanoids-such as catheter-related infections and intolerable adverse effects-may develop, prompting transition to inhaled prostanoids. We repo...
Main Authors: | , , , |
---|---|
Other Authors: | |
Language: | en |
Published: |
UNIV CHICAGO PRESS
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/622493 http://arizona.openrepository.com/arizona/handle/10150/622493 |